Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in NASH
NCT01068444Phase 2Completed
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Apr 2009
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in Nonalcoholic steatohepatitis (NASH), sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Started Apr 2009; status: completed.
02
Drugs
pioglitazone
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT01068444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01068444.